Division of Nephrology & Hypertension
Mayo Clinic, 200 First Street SW
Rochester, MN 55905
Phone: 507-266-1047 or 507-255-0231
Fernando Fervenza, MD, PhD
Marie Hogan, MD, PhD
John Lieske, MD
For information related to NEPTUNE, contact Research Coordinators listed below:
The Mayo Clinic Division of Nephrology was established in 1963. The combined Division of Nephrology and Hypertension is now comprised of 39 faculty members and is one of the world’s largest groups dedicated to the study of the kidney, hypertension, and the treatment of patients with renal diseases and hypertension. The Mayo Clinic Division of Nephrology and Hypertension was ranked first nationally in the 2010, 2011, 2013, 2014, and 2015 US News and World Reports surveys, and a close second in 2012.
The Mayo Nephrology Collaborative Group (MNCG) is a consortium of nephrologists including Mayo Clinic Rochester, Jacksonville, and Scottsdale, and clinical and academic nephrologists located across the United States interested in developing and conducting prospective studies aimed at treating patients with renal parenchymal diseases. Established in 1988 by Dr. James V. Donadio Jr. and collaborators, the consortium has grown to now encompass 30 clinical centers and involves the participation of over 100 physicians and coordinators who are seeing the vast majority of patients with parenchymal renal diseases early in the course of illness, at a time when promising new therapies may exert their greatest influence.
The members of the MNCG believe strongly that clinical research goes hand in hand with our roles as clinicians and educators, and that this research is crucial for developing new therapies for patients with renal parenchymal diseases and have more than 10 clinical studies and disease registries. MNCG members are instrumental in design and leading of clinical trials in glomerular disease and other renal diseases and participate in several NIH sponsored multicenter collaborative initiatives in glomerular disease, other renal diseases and translation of new diagnostic and prognostic tests into clinical practice. In addition, the work of the MNCG leads to the rapid diffusion of new discoveries because of the number of practices it affects. Both from the intra- and extramural point of view, the role of the clinical research conducted by the MNCG, has contributed to better patient care, and has served an educator to the nephrology community worldwide through its publications.
Mayo Nephrology Collaborative Group (MNCG) Clinical Trials